Table 3.
Univariate and multivariate analyses of predictive factors for overall survival
| Variables | Univariate analyses |
Multivariate analyses |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
| Age | 0.996 | 0.967–1.026 | 0.81 | 0.983 | 0.955–1.012 | 0.26 |
| Male | 0.627 | 0.297–1.321 | 0.22 | 1.714 | 0.803–3.661 | 0.16 |
| Resection group | 0.582 | 0.346–0.979 | 0.04 | 0.541 | 0.317–0.922 | 0.02 |
| Etiology (HBV) | 0.414 | 0.165–14.731 | 0.06 | - | - | - |
| Main portal vein invasion | 3.578 | 0.869–2.530 | 0.14 | - | - | - |
| Segmental portal branch invasion | 1.462 | 0.845–2.530 | 0.18 | - | - | - |
| Multiple tumor | 1.581 | 0.948–2.635 | 0.08 | - | - | - |
| Massive type of tumor | 1.258 | 0.742–2.133 | 0.39 | - | - | - |
| mUICC stage (III) | 0.731 | 0.438–1.220 | 0.23 | - | - | - |
| AFP > 200 ng/mL | 1.148 | 0.660–1.997 | 0.63 | - | - | - |
| Thrombocytopenia | 1.038 | 0.621–1.738 | 0.89 | - | - | - |
| Size > 5 cm | 1.621 | 0.696–3.776 | 0.26 | - | - | - |
HR, hazard ratio; CI, confidence interval; HBV, hepatitis B virus; mUICC, modified the Union for International Cancer Control; AFP, alpha-fetoprotein.